Bausch Health Companies Inc. (BHC): Price and Financial Metrics

Bausch Health Companies Inc. (BHC)

Today's Latest Price: $27.74 USD

0.31 (1.13%)

Updated Feb 14 6:40pm

Add BHC to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

BHC Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for BHC is 3.42 -- better than 84.8% of US stocks.
  • BHC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 96.22% of US stocks.
  • Over the past twelve months, BHC has reported earnings growth of -129.64%, putting it ahead of merely 10.75% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Bausch Health Companies Inc, a group of peers worth examining would be BC, TEVA, HAS, ENDP, and CE.
  • BHC's SEC filings can be seen here. And to visit Bausch Health Companies Inc's official web site, go to
BHC Daily Price Range
BHC 52-Week Price Range

BHC Stock Price Chart More Charts

BHC Price/Volume Stats

Current price $27.74 52-week high $31.97
Prev. close $27.43 52-week low $18.72
Day low $27.23 Volume 3,621,000
Day high $28.01 Avg. volume 3,082,781
50-day MA $29.07 Dividend yield N/A
200-day MA $24.89 Market Cap 9.78B

Bausch Health Companies Inc. (BHC) Company Bio

Bausch Health Cos. Inc. (formerly) Valeant Pharmaceuticals is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter products, and medical devices, including contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices. The company was founded in 1983 and is based in Laval, Canada.

BHC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

Below please find a table outlining a discounted cash flow forecast for BHC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Bausch Health Companies Inc ranked in the 45st percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Bausch Health Companies Inc, consider:

  • 29% of the company's capital comes from equity, which is greater than merely 8.74% of stocks in our cash flow based forecasting set.
  • Bausch Health Companies Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 0.51. This coverage rate is greater than that of merely 21.34% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • As a business, Bausch Health Companies Inc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than only 0% of stocks generating free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as BHC, try ANTM, TARO, ENTA, HBIO, and STE.

BHC Latest News Stream

Event/TimeNews Detail
Loading, please wait...

BHC Latest Social Stream

Loading social stream, please wait...

View Full BHC Social Stream

BHC Price Returns

1-mo -8.30%
3-mo 0.04%
6-mo 25.52%
1-year 9.00%
3-year 72.94%
5-year N/A
YTD -7.29%
2019 61.99%
2018 -11.12%
2017 43.11%
2016 -85.72%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6281 seconds.